Vitrolife AB's Total Assets for the quarter that ended in Sep. 2024 was kr16,884 Mil.
Warning Sign:
If a company builds assets at 94.4% a year, faster than its revenue growth rate of 20.1% over the past 5 years, it means that the company may be getting less efficient.
During the past 12 months, Vitrolife AB's average Total Assets Growth Rate was -21.80% per year.
During the past 3 years, the average Total Assets Growth Rate was 126.50% per year.
During the past 5 years, the average Total Assets Growth Rate was 94.40% per year.
During the past 10 years, the average Total Assets Growth Rate was 44.30% per year.
During the past 13 years, Vitrolife AB's highest 3-Year average Total Assets Growth Rate was 149.80%. The lowest was -4.70%. And the median was 13.60%.
The historical data trend for Vitrolife AB's Total Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
Vitrolife AB's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note:
The Net Income data used here is four times the quarterly (Sep. 2024) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
Vitrolife AB's Asset Turnover for the quarter that ended in Sep. 2024 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
Vitrolife AB Total Assets Related Terms
Thank you for viewing the detailed overview of Vitrolife AB's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.
Vitrolife AB provides medical devices and genetic testing services intended for the reproductive-health market in the field of reproductive health. The company develops, manufactures, and distributes medical devices and provides genetic testing services for IVF clinics and their patients. Its mission is to support IVF clinics (in vitro fertilization) in enhancing their practice as well as the outcome of a patient's fertility treatment, thereby enabling patients to receive support to navigate the complexities of reproductive health through successful outcomes and patient satisfaction. The group has three geographical segments EMEA, Americas and APAC, out of which it derives maximum revenue from EMEA.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LTS:0YAY has been successfully added to your 